- infusion-related reactions. They are more
expensive than
amphotericin B deoxycholate.
AmBisome (liposomal
amphotericin B; LAMB) is a
liposomal formulation of amphotericin...
- NeXstar's
annual sales of $130
million was
three times Gilead's sales; it sold
AmBisome, an
injectable fungal treatment, and DaunoXome, an
oncology drug taken...
- 2017
AmBisome Intravenous:
WebMD -
Retrieved January 16, 2017
Amphotec Intravenous:
WebMD -Retrieved
January 16, 2017
AmB
colloidal versus AmB deoxycholate:...
- injection) –
Pharmacologic stress agent for
myocardial perfusion scan
AmBisome (amphotericin B) – Anti-fungal –
marketed with
Gilead Sciences. Amevive...
- "Comparison of
three treatment regimens with
liposomal amphotericin B (
AmBisome) for
visceral leishmaniasis in India: a
randomized dose-finding study"...
- Ambi 10
ambicromil (INN)
Ambien (Sanofi-Aventis), also
known as
zolpidem Ambisome Ambodryl ambomycin (INN)
ambroxol (INN)
ambruticin (INN)
ambucaine (INN)...
- also have the
potential for
localized treatment in
fungal infections.
AmBisome (L-AMB) is an LTL that
contains Amphotericin B (AMPH-B), an anti-fungal...
-
develops and
commercializes therapeutics will
donate 445,000
vials of its
AmBisome over five
years (equivalent to $8 million) for
treatment of
visceral leishmaniasis...
- Bicanic,
Rahuman Salim,
William Hop (2016). "Liposomal
Amphotericin B (
AmBisome®): A
review of the pharmacokinetics, pharmacodynamics,
clinical experience...
-
through the
negotiations of
Investment Banker, Paul M. Michaels,
licenses Ambisome and
Danisome for the
Asian marketplace from a U.S.
Pharmaceutical company...
